期刊文献+

多西他赛联合替吉奥胶囊治疗晚期胃癌23例临床观察

下载PDF
导出
摘要 胃癌是我国人群的最重要死因之一,发病率呈逐年增高趋势,且复发、转移性胃癌更难以治愈,治疗后的中位存活时间仅为2~3年.治疗的主要日的是缓解症状和改善生活质量。2011年5月-2012年5月我院对收治的23例晚期胃癌患者应用多西他赛联合替吉奥胶囊(S-1)方案进行治疗,不仅提高了晚期胃癌的近期疗效,而且毒副反应较轻,耐受性好,取得了较好的临床效果,现总结报告如下。
出处 《中国初级卫生保健》 2013年第3期96-97,共2页 Chinese Primary Health Care
  • 相关文献

参考文献5

二级参考文献18

  • 1Maindrault-Goebel F,De Gramont A,Louvet C,et a1.Evalua tion of oxaliplatin dost intensity in bimonthly in leucovorin and 48-hour 5-flu orouracil continuous infusion regimens (FOLFOX) in pretreated metastatic colorec tal cancer[J].Ann Oncol,2000,11∶1477. 被引量:1
  • 2Wasserman E,Cuvier C,Lokiec F,et a1.Combination of oxa liplatin Plus irinotecan in patients with gastrointestinal tumors:results of tw o independent phase Ⅰ studies with pharmacokinetics[J].J Clin Oncol,1 999,17∶1751. 被引量:1
  • 3Raymond E,Faivre S,Woynarowski JM,et al.Oxaliplatimech anisn of action and antineoplastc activity[J].Sem Omcol,1998,2(Supple 5):4. 被引量:1
  • 4Eriguchi M,Osada I,Fujii Y,et a1.Pilot study for pre operative administration of l-OHP to patients with advanced scirrhous type gastr ic cancer[J].Biomed Pharmacother,1997,51:217. 被引量:1
  • 5De Gramont,Vignoud J,Toumigand C,et a1.Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous in pretreated met astatic colorecral cancer[J].Eur J Cancer,1997,33:214. 被引量:1
  • 6Raymond E,Lawrence R,Izbicka E,et a1.Activity of oxali platon against human tumor colony-forming units[J].Clin Cancer Res,19 98,4:1021. 被引量:1
  • 7Taguchi T,Tsukagoshi S,Furue,et a1.Phase I clinical st udy of oxaliplatin[J].Gan To Kagaku Ryoho,1998,25:1899. 被引量:1
  • 8Kin DY,Kim JH,Lee SH,et al.Phase Ⅱ study of oxaliplatin,5-fluorouracil and leucovorin in previously platinunr treated patients with advanced gastric cancer[J ].Ann Oncol,2003,14(3):383. 被引量:1
  • 9AI-B atran SE,Atmaca A,Hegewisclr BeckerS,et al.Phase Ⅱ trial of biweekly infusinal fluorouracil,folinic acid,andoxaliplatin in patients with advanced gastric cancer[J ].Clin Oncol,2004,22:658. 被引量:1
  • 10Fossella F, Pereira JR, von Pawel J, et al. Randomized, multinational, phase Ⅲ study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer:the TAX 326 study group [ J ]. J Clin Oncol, 2003,21 (16) :3007 -3008. 被引量:1

共引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部